Deep Tech Startups

ClicBio develops oral small-molecule CLIC1 inhibitors to treat metabolic diseases by modulating appetite through hypothalamic neuron regulation. The company targets obesity and metabolic disease through a mechanism that acts independently from and additively with GLP-1 agonists.

1 investor

CLLEVERT develops a patented capillary liquid–liquid extraction insert for pre-analytical sample preparation, using a precision capillary with a hydrophilic or hydrophobic orifice to selectively separate liquid phases. The device targets biomedical and research laboratories, pharmaceutical production, food science, and environmental testing, and its technology is offered for licensing.

1 investor

Cloudberry is a €30M early-stage venture capital fund investing €400K to €1M into pre-seed and seed startups working on semiconductors, photonics, and advanced materials, mainly in Europe. It backs companies across the semiconductor value chain, from design tools and metrology to compute, electronics, and photonic sensing systems.

1 investor

Clyde Biosciences is a contract research organization offering predictive cardiac safety and efficacy testing using human iPSC-derived cardiomyocyte models, aimed at pharmaceutical and biotech teams assessing cardiotoxicity for clinical translation. It provides functional cardiac safety data aligned with regulatory guidance, including the CiPA Assay.

1 investor

Clyde Hydrogen develops modular hydrogen production systems ranging from 100kW to 100MW+ for applications including emergency backup power, industrial energy storage, and mobility refueling. The company's technology uses standardized modules (reductor, storage, and reactor) to enable flexible, scalable hydrogen generation and storage.

1 investor

CO2Volt develops high-performance acidic CO₂ electrolysers that convert captured carbon dioxide into valuable chemicals, fuels, and industrial feedstocks. The company's technology targets hard-to-abate industries including aviation (sustainable aviation fuel), semiconductors, steel, and glass, with significantly improved durability and selectivity compared to conventional electrolysers.

1 investor

Coagulo develops a portable point-of-care testing platform for coagulation disorder diagnosis and management using microfluidic technology and data analytics. The platform enables healthcare providers to perform comprehensive coagulation testing with drops of blood and deliver results within 10 minutes.

1 investor

Coanda is an engineering and R&D consulting firm that helps clients diagnose the root of technical problems, resolve industrial process challenges, and develop new technology through services such as physical modeling, mathematical modeling, and geotechnical analysis. It serves industrial clients across sectors including fine tailings management and membrane-based processes.

1 investor

Coastal Carbon develops artificial intelligence trained on satellite data to monitor and understand natural systems, with a focus on climate and environmental applications including ocean-based carbon solutions.

1 investor

Coastar Therapeutics develops a gene delivery technology based on Erythrocyte Derived Membrane (EDM) designed to shield genetic medicines from immune clearance and deliver them to targeted sites. The company operates in the genetic medicine and biotechnology field.

1 investor

Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver. The platform is designed for re-dosing, delivery of large gene constructs approaching 10kb, and modular manufacturing for genetic medicine development.

1 investor

A company that seeks to find, develop, and help bring emerging technologies to market.

1 investor

Codelucida develops error-correction coding technology for flash memory (NAND) storage. Its solutions target flash memory and storage device makers.

1 investor

Codexis provides enzyme engineering and biocatalysis services for RNA and small molecule API manufacturing, offering RNAi/siRNA and enzymatic synthesis solutions to pharmaceutical partners. It supports customers from process development through scalable commercial supply using an in-house pilot plant and CMO network.

1 investor

CoFound is an early-stage venture firm that invests in founders from the "ambition stage" and works closely with them on go-to-market strategy and finding product-market fit. It focuses on areas including deep tech and AI.

1 investor

CognaSIM offers an AI-powered, cloud-based simulation platform that integrates with existing engineering simulation tools to make them more accessible to engineers and product development teams. It aims to speed up simulation workflows so teams can design, test, and optimize without needing specialist tools or training.

1 investor

Cognigenics is developing iRNAi, a non-invasive intranasal RNA interference platform that delivers programmable RNA therapeutics directly to targeted brain circuits, bypassing the blood-brain barrier to modulate mood, memory, and cognition. The company focuses on precision neuropsychiatry and treatments for neurological and psychiatric disorders.

1 investor

RZX Tecnologia develops neuroscience-based solutions to improve safety and efficiency in oil and gas drilling operations by optimizing cognitive performance and reducing human error in complex operational environments.

1 investor

Coherence Bio makes Keystone, a benchtop laboratory instrument that integrates cell culture, fluid handling, scheduled interventions, and multimodal imaging into a single uninterrupted multi-day run. It is aimed at research labs running organoid, spheroid, and other multi-day cell biology protocols such as longitudinal phenotyping and drug response kinetics.

1 investor

Coherent Biopharma (Tongyi Pharmaceutical) is a biopharmaceutical company developing its proprietary Bi-targeting XDC (bi-XDC) conjugate drug platform to make previously undruggable targets treatable, with a focus on oncology. It has a pipeline of first-in-class candidates and clinical trials across multiple cancer indications, operating in China, the U.S., and Australia.

1 investor

Coinplug (CPLABS) builds blockchain-based infrastructure and technology, working with financial, telecom, and government organizations on digital identity and related projects. Founded in 2013, the company holds numerous patents and serves partners primarily across Asia.

1 investor

Colimit offers a coding agent for formal spec-driven development, guiding users to write formal specifications without prior experience, check specs for logical bugs, and generate code by combining compilers with LLMs. It also verifies that the generated implementation matches the specification.

1 investor

Columbiad Launch Services is a commercial space launch company developing a high-volume Industrial Sounding System based on gun propulsion technology to provide low-cost access to space.

1 investor

Compound Eye builds camera-based sensing and perception technology (VIDAS) that combines AI with classical computer vision to give autonomous machines depth measurement, scene understanding, and positioning without LiDAR or radar. It serves defense, heavy equipment (construction and mining), and automotive applications.

1 investor